Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02009449
Title A Phase 1 Study of AM0010 in Patients With Advanced Solid Tumors
Acronym IVY
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors ARMO BioSciences
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Medical Hematology & Oncology Los Angeles California 90024 United States Details
UCSF San Francisco California United States Details
Sarah Cannon Research Institute at HealthONE Denver Colorado 80218 United States Details
Florida Cancer Specialists & Research Institute Sarasota Florida 34232 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Stephenson Cancer Center at Oklahoma University TSET Phase 1 Program Oklahoma City Oklahoma 73104 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
The University of Texas M.D. Anderson Cancer Center Houston Texas 77030 United States Details
South Texas Accelerated Research Therapeutics San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field